Association of inflammation with anaemia in patients with chronic kidney disease not requiring chronic dialysis

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2879-2883

  Chonchol, Michel ^a   Lippi, Giuseppe ^b   Montagnana, Martina ^b   Muggeo, Michele ^b   Targher, Giovanni ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Anaemia; Chronic kidney disease; Inflammation

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANEMIA; C-REACTIVE PROTEIN; COMORBIDITY; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; INFLAMMATION; MALE; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58549116511     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn109     Document Type: Article

References (26)

1. Vlagopoulos PT, Tighiouart H, Weiner DE et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 2005; 16: 3403-3410
2. Drüeke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. New Engl J Med 2006; 355: 2071-2084
3. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoietin alfa in chronic kidney disease. New Engl J Med 2006; 355: 2085-2098
4. Levin A. Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 2007; 22: 309-312
5. Singh AK. Anemia of chronic kidney disease: CHOIR and the FDA. Nat Clin Pract Nephrol 2007; 3: 406-407
6. KDOQI. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471-530
7. Drüeke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001; 16(Suppl 7): 25-28
8. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001; 16(Suppl 7): 36-40
9. Bárány P, Divino F, Bergström J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997; 29: 565-568
10. Tonelli M, Blake PG, Muirhead N. Predictors of erythropoietin responsiveness in chronic hemodialysis patients. ASAIO 2001; J47: 82-85
11. Kwack C, Balakrishnan VS. Managing erythropoietin hyporesponsiveness. Semin Dial 2006; 19: 146-151
12. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007; 49: 2129-2138
13. Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772
14. Astor BC, Muntner P, Levin A et al. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002; 162: 1401-1408
15. Macdougall IC, Cooper A. The inflammatory response and epoetin sensitivity. Nephrol Dial Transplant 2002; 17: 48-52
16. Singh D, Whooley MA, Ix JH et al. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007; 22: 1087-1092
17. Phrommintikul A, Haas SJ, Elsik M et al. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007; 369: 381-388
18. Tobu M, Iqbal O, Fareed D et al. Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor. Clin Appl Thromb Hemost 2004; 10: 225-232
19. Eustace JA, Astor B, Muntner PM et al. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004; 65: 1031-1040
20. Nangaku M, Eckardt KU. Pathogenesis of renal anemia. Semin Nephrol 2006; 26: 261-268
21. Cooper AC, Mikhail A, Lethbridge MW et al. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol 2003; 14: 1776-1784
22. Selleri C, Maciejewski JP, Sato T et al. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 1996; 87: 4149-4157
23. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 1993; 91: 416-419
24. Lahera V, Goicoechea M, de Vinuesa SG. Oxidative stress in uremia: the role of anemia correction. J Am Soc Nephrol 2006; 17(Suppl 3): S174-S177
25. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557
26. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003; 14: 1927-1939